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ABSTRACT 
Background and Objectives: Brucellosis is one of the most common zoonotic diseases in Iran and human brucellosis is 
endemic in all parts of the country. Because of the difficulty in the diagnosis of brucellosis, particularly in endemic areas, the 
use of new and feasible diagnostic tests seem to be of great importance for resolving the diagnostic obstacles. We evaluated 
the usefulness of a new serological test based on an immunocapture-agglutination technique in comparison with ELISA test 
for serological diagnosis of brucellosis.
Materials and Methods: A total of 11 patients with brucellosis, who had positive blood cultures for Brucella species, and 
47 suspected patients were included in this study. Serum samples collected from these patients were tested by brucellacapt 
and ELISA and the results were, consequently, compared. 
Results: In patients with positive blood culture, all the samples gave positive results with brucellacapt test while IgM ELISA, 
IgG ELISA and (IgG + IgM) ELISA tests were positive in 8, 9 and 11 patients, respectively. Out of the 46 suspected patients, 
(IgG + IgM) ELISA, Brucellacapt, IgG ELISA and IgM ELISA were positive in 37, 15, 34 and 37 patients, respectively.The 
best cut-off point of ELISA-IgG was 10.78 IU/ml  which produced the maximal sensitivity and specificity for the diagnosis 
of human brucellosis. 
Conclusion: Both the (IgG + IgM) ELISA and Brucellacapt tests demonstrate a high specificity in this study. According to 
the results of the current study, it is found that both tests are valuable tools for diagnosis of brucellosis in Iran as an endemic 
area of brucellosis. It is strongly suggested that a combination of both tests to be used for the diagnosis of brucellosis.
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INTRODUCTION
Brucellosis is a major public health concern in 
developing countries. The disease is found worldwide, 
but is more common in the Mediterranean countries, 
the Arabian Peninsula, Indian subcontinent and in 
parts of Mexico and Central and South America (1, 2). 
In Iran, brucellosis represents a major health problem 
and is being reported with increasing frequency from 
various parts of the country. Brucellosis is quite a 
common disease throughout the country (3), the 
diagnosis of which is frequently difficult to establish. 
This is not only because the disease clinically mimics 
other infectious and non-infectious diseases, but 
also because the established diagnostic methods are 
not always successful in isolating the organism (4). 
The laboratory confirmation of human brucellosis 
is based on the microbiological, serological or 
molecular methods, each having its own advantages 
and disadvantages. Many serological tests such as 
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ELISA, Standard agglutination test (Wright) and 
Coombs Wright test are used for the diagnosis of 
human brucellosis, among which serological tests 
have a key role in the rapid and proper diagnosis. 
In addition to the fact that serological tests are easy 
and safe to use, these tests are quite inexpensive (5, 
6). Standard agglutination test, the most common 
and important serological test, is used for diagnostic 
purposes in Iran. However, disadvantages of this test 
include the possibility of false negative results due to 
the presence of blocking antibodies in addition to the 
low specificity of the test in endemic area due to the 
presence of high antibody prevalence in the healthy 
population. Therefore, in endemic areas, the diagnosis 
of brucellosis should be confirmed by bacterial 
isolation which is mostly done by blood culture. This 
bacterium is very slow growing, requiring seven days 
or more to grow. The sensitivity of blood culture is 
usually low (50 - 90 % in various studies) depending 
on the disease stage, Brucella species, type of the 
medium and technique used. Moreover, the risk of 
transmission of the infection, during blood culture, 
threatens the laboratory personnel (7, 8).
In the recent years, automated blood culture 
systems have been developed that reduce the bacterial 
growth time to a week or less. In case of no access 
to automated systems for the isolation of Brucella, 
specific media, subculture and prolonged incubation is 
required. Improved new technologies are not usually 
available in the rural areas and developing countries 
(3, 9). Recently, Fatolahzadeh and colleagues have 
introduced a new medium for the isolation of Brucella, 
named as TUMS medium. Since in endemic areas, the 
definitive diagnosis of brucellosis requires isolation 
of bacteria and TUMS medium is very efficient for 
the isolation of Brucella from patients, so the use of 
this medium is very helpful (10).
The development of new diagnostic techniques 
that facilitate rapid detection and identification 
of brucellae and minimize the risk of laboratory 
infection is of great practical importance and it seems 
that Brucellacapt kit is one of the best options among 
the new diagnostic methods (11).
Several studies claim that the technology used in the 
Brucellacapt kit is unique and very useful in detecting 
both the acute and chronic diseases which is applicable 
in brucellosis-endemic areas. Other advantages of 
Brucellacapt test are immediate performance, simple 
use and handling, simple package kit including all 
the reagents, no need of washing and easy reading 
in 24 hours (12, 13). The aim of this study was to 
evaluate Brucellacapt technique as a diagnostic test 
for human brucellosis in comparison with (IgG + IgM) 
ELISA test.
MATERIALS AND METHODS
Individuals included in this study were divided into 
three groups. The first group included 11 patients 
who had a positive blood culture. The second group 
included 46 individuals, who had clinical symptoms 
and signs of brucellosis, but blood cultures were not 
performed for them and the third group included 32 
healthy persons used as control. A total of 89 serum 
samples were obtained from these three groups and the 
Standard agglutination test (SAT), Brucellacapt, and 
ELISA for IgM and IgG antibodies were performed 
on each serum sample. All the samples from a 
given patients were processed simultaneously. The 
Brucellacapt test (Vircell Company, Spain) is based 
on an immunocapture agglutination method and, in 
a single step, detects agglutinating antibodies as well 
as non-agglutinating IgG and IgA antibodies. The 
test was performed according to the manufacturer’s 
instructions: Briefly, 50 μl of each serum diluents 
was added to a microplate with U-shaped wells, pre-
coated with antihuman immunoglobulin, and then 
5 μl of serum samples were added to each well and 
subsequently 50μl of an antigen suspension (colored 
B. melitensis bacteria killed by formaldehyde treatment) 
was added to all the wells. The plate was sealed with 
adhesive tape to avoid evaporation of the liquid in 
microplate wells and incubated for 18–24 h at 37°C in a 
dark humid chamber before visualizing the microplate. 
Positive reactions show agglutination over the bottom of 
the well. Negative reactions were confirmed by a pellet 
in the center bottom of the well (13).
SAT test materials were supplied by Pasture 
Institute (Tehran, Iran), while IgG, IgM ELISA kits 
were manufactured by Vircell Company, Spain. 
Briefly, the procedures of these tests are as follows:
The SAT test was performed in tube by a double-
dilution method from an initial 1/20 dilution. SAT 
reactions were read after 24 h incubation at 37°C. 
The highest serum dilution, showing more than 50% 
agglutination, was considered the agglutination titer 
(14). 
The IgM and IgG sandwich ELISA tests were 
performed using the commercial kit. Separate microplat- 
es for IgM and IgG were used. The principle of IgM and 
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IgG ELISA was that the plate wells were coated with 
LPS antigen of Brucella abortus to bind corresponding 
antibodies of the patient sera samples. In the first 
step, the serum antibodies were bound to the existing 
antigens in the well. After washing the wells to remove 
all the unbound antibodies, the anti human IgM or 
IgG secondary antibody conjugated to the enzyme 
peroxidase was added. The intensity of the created color, 
that was in accordance with the amount of serum IgG or 
IgM, was read in the wavelength of 450 nanometer.  An 
intensity value less than 9 were considered as negative 
and a value more than 11 as positive (15).   
RESULTS
The efficacy of the two serological tests (ELISA and 
Brucellacapt), on detecting anti Brucella antibodies, 
was evaluated on a total of 89 serum samples.
In the first group, including 11 patients with a positive 
blood culture, Brucellacapt, IgM and IgG ELISA tests 
were positive in 11, 8 and 9 patients, respectively. The 
IgM and IgG ELISAs failed to detect specific antibodies 
in 3 and 2 confirmed patients, respectively. On the 
other hand, Brucellacapt test was positive for all the 11 
confirmed patients and its efficacy was equal to the (IgG 
+ IgM) ELISA test. The serum samples from healthy 
individuals were uniformly detected as negative by the 
IgM and IgG ELISA tests, while one serum sample, 
from these healthy individuals, was detected as positive 
by the Brucellacapt test (Table 1). All samples from the 
control group were negative by the IgM and IgG ELISA 
tests (Table 1).
The sensitivity and specificity of Brucellacapt, 
IgM ELISA, IgG ELISA and (IgG + IgM) ELISA are 
summarized in Table 2. To determine the specificity 
of serological tests, sera from 32 healthy donors were 
included in this study. No significant difference was 
established between the specificity of Brucellacapt, 
(IgG + IgM) ELISAand IgG or IgM ELISA tests. Only 
one healthy donor had a positive Brucellacapt test 
(specificity, 96.8%). All the controls were determined 
as negative by the SAT and ELISA tests (specificity, 
100%).
The area under the ROC curve, for the discrimination 
of the positive and negative brucellosis groups, was 
significantly (P < 0.0001) different from 0.5 (Fig. 
1). Sensitivity and specificity were calculated for 
different levels of IgG ELISA. Compared to other 
cut-off points of IgG ELISA, the cut-off point of 
10.78 IU/ml produced the highest sensitivity and 
specificity and it was, consequently, considered the 
best cut-off point of IgG ELISA for the diagnosis of 
human brucellosis. At this point, the sensitivity and 
specificity were 100 and 100%, respectively (Table 3).
DISCUSSION
 Serological tests have many advantages including 
simplicity of performing, low cost and no risk of 
infection for laboratory personnel. However, the 
fundamental weak spot of serological tests is their 
low specificity, especially in endemic areas. 
In Iran, as an endemic area of brucellosis, the 
diagnostic values of different serological methods 
Group No. of Persons
Brucellacapt
POS (%)    NEG (%)
ELISA/IgM
POS (%)     NEG (%)
ELISA/IgG
POS (%)     NEG (%)
ELISA (IgG + IgM)
POS (%)      NEG (%)
Positive blood culture 11     11 (100)      0 (0)            8  (72.7)        3 (27.3)  9 (81.8)         2 (18.2)      11 (100)        0 (0)        
Suspected patients 46    37 (80.4)    9 (19.6)       15 (32.6)       1 (67.4)  34 (73.9)        2 (26.1)      37 (80.4)     9 (19.6)      
Healthy persons 32      1 (3.2)     31 (96.8)       0 (0)          32 (100)        0 (0)           32 (100)     0 (0)          32 (100)    
Table 1. Results from the sera of brucellosis patients and controls in serological tests.
Sensitivity Specificity
Brucellacapt 80.4 96.8
IgM ELISA 40.6 100
IgG ELISA 75.4 100
(IgM + IgG) ELISA 80.4 100
Table  2. Sensitivity and Specificity of the Brucellacap and 
ELISA tests in the sera of 11 confirmed and 46  suspected 
patients of brucellosis. ELISA titers (10.78)   Sensitivity Specificity
10.78 100 100
12.41 88.89 100
14.19 77.79 100
15.35 66.67 100
16.74 55.56 100
Table 3. The power of different IgG ELISA titers in the 
diagnosis of human brucellosis.
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for the diagnosis of human brucellosis have been 
compared in a few studies. In a study conducted by 
Vakili et al., which included 457 individuals with 
clinical presentation of brucellosis and a control group 
with 50 healthy individuals, sensitivity and specificity 
were found as 93.7% and 70.6% for IgG ELISA and 
12.5% and 100% for IgM ELISA, respectively (16).
In another study, Mohraz et al., reported that the 
sensitivity and specificity of IgG ELISA were 93% 
and 100%, respectively (17). The sensitivity of IgG 
ELISA in this study was less than that reported in 
the studies of Mohraz et al., (93%) and Vakili et al. 
(93.7%). However, the sensitivity of IgM ELISA in 
the current study was higher than that in Vakili et 
al., (12.5%) study. The specificity of IgG ELISA of 
Mohraz et al., study (100%) and IgM ELISA of Vakili 
et al., study (100%) support the result of this study.
According to the literature review, this is the 
first study in Iran to assess the diagnostic value 
of Brucellacapt test for the diagnosis of human 
brucellosis and, therefore, the comparison between 
the Brucellacapt results with those in other Iranian 
studies is not possible. Orduna et al., compared 
the sensitivity and specificity of Brucellacapt and 
coombs tests on the serum samples of 82 definite 
patients, whose disease was confirmed by blood 
culture, 157 suspected patients of brucellosis and 
412 individuals from people living in rural areas 
with endemic of brucellosis as control. Their study 
showed that the Brucellacapt and coombs tests had 
similar sensitivity and specificity for diagnosis of 
human brucellosis. They announced that Brucellacapt 
test is more sensitive and usually showed higher titers 
than coombs test, although when titers less than 1/320 
were used as diagnostic threshold the test specificity 
slightly decreased (15).
In a study conducted by Ozdemir et al., 200 serum 
samples of suspected patients of brucellosis were 
assessed and it was found that the sensitivity of 
Brucellacapt test was similar to (IgG + IgM) ELISA 
in the means of brucellosis diagnosis. The results 
obtained by Ozdemir et al., are quite consistent with 
the results of the current study (18).
The difference between the results obtained by 
ELISA and Brucellacapt tests in various studies can 
be explained in several aspects. The selection of a gold 
standard is the most important and difficult step in the 
studies including diagnostic tests. Some investigators 
believe that finding a true gold standard is not achievable 
and for this reason, finding a diagnostic test that is able 
to completely differentiate between patients and healthy 
individuals is impossible. However, the establishment of 
an operational standard for measuring the accuracy of 
diagnostic tests in all studies is very important and has 
very influential effects on the results of studies (19).
In Various studies that have been conducted to 
determine the efficacy of diagnostic tests, different 
gold standards have been used. Criteria for the 
selection of patients in the present study were based 
on a positive blood culture or a positive Wright test ≥ 
1/160, while in the study of Vakili et al., patients were 
selected on a clinical-symptom basis.
It is quite obvious that different criteria for the 
selection of patients affect the study results. Various 
antigens used in kits can be another reason for the 
different results of different studies. In this study, 
we used ELISA and Brucellacapt kits, manufactured 
by Vircell Company. Ozdemir et al. used the same 
kits whilst the ELISA kit used by Vakili et al., was 
manufactured by the IBL Company.
In conclusion, the main drawback of serological 
tests, in endemic areas, is the low specificity 
level. Both the ELISA and Brucellacapt tests have 
demonstrated a high specificity in the current study 
and this is an advantage for these tests. Based on the 
results of this study, it can clearly be found that the 
Brucellacapt and the (IgG + IgM) ELISA tests are 
valuable tools for diagnosis of brucellosis in Iran as 
an endemic area of brucellosis. 
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Fig. 1. Receiver Operating Characteristic (ROC) curve 
distinguishing between patients confirmed with brucellosis 
and those without the disease (control group) diagnosed by 
IgG ELISA assay.
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